Havea
Established: 1975
Country: France
Region: Pays de la Loire
Investors: 3i Group
Havea is a leading European natural healthcare player featuring a unique consumer/patient-centric approach centered on five strategic brands: Aragan, Biolane, Densmore, Dermovitamina and Vitavea each with their own go-to-market proposition and consumer group.
The business is headquartered in Paris and Nantes and helps consumers prevent and treat common health issues with premium natural healthcare products. Powered by innovation and with a focus on sustainability - both at the core of Havea’s DNA - the company is dedicated to improving personal wellbeing by empowering consumers to take care of their health using natural and organic products.
5
acquisitions in 5 years
60
litres of water saved per bottle
50%
scope 1-3 emissions saved by 2030
Our partnership with 3i has been very successful. With their active support, Havea has grown substantially and established its leadership position in natural healthcare. We have laid all the right foundations to become the reference player, with a continued focus on improving our consumers’ quality of life with natural products.
Key achievements
completed 5 acquisitions in 5 years
increased Havea’s EBITDA margin from 22% to 28% and tripled EBITDA
reinforced its presence in Belgium and Italy
simplified its brand portfolio by moving to a consumer/patient-centric approach and reducing its brands from 40 to 5 strategic ones
implemented a complete multichannel strategy (e.g. the launch of D2C subscription service)
improved the circularity of packaging using recycled raw materials, refillable packaging and a reduction in packaging waste; and product innovation following eco-design principles, such as a new shampoo formula which saved 60 litres of water per bottle
ESG: invested in a water treatment facility and a heat pump installation; introduced an EV fleet; completed its first carbon footprint assessment in 2020 and committed to reduce scope 1-3 emissions by 50% by 2030
Funding history
Invested €150m in Ponroy (subsequently renamed Havea) in 2017
Exited in 2022 with proceeds to 3i of €540m, 3.0x MM, 23% IRR
Sold for an enterprise value of €1.1bn
Find out more
Investors
